Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other financing activities: 2023-2025

Historic Other financing activities for CG Oncology (CGON) over the last 1 years, with Sep 2025 value amounting to $270,000.

  • CG Oncology's Other financing activities was N/A to $270,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$314,000, marking a year-over-year change of. This contributed to the annual value of -$3.4 million for FY2024, which is 0.09% down from last year.
  • Latest data reveals that CG Oncology reported Other financing activities of $270,000 as of Q3 2025, which was up 185.71% from -$315,000 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Other financing activities ranged from a high of $270,000 in Q3 2025 and a low of -$3.4 million during Q1 2024.
  • Its 3-year average for Other financing activities is -$1.1 million, with a median of -$273,500 in 2025.
  • Within the past 5 years, the most significant YoY rise in CG Oncology's Other financing activities was 93.15% (2025), while the steepest drop was 751.35% (2025).
  • CG Oncology's Other financing activities (Quarterly) stood at -$3.2 million in 2023, then reached -$37,000 in 2024, then crashed by 751.35% to $270,000 in 2025.
  • Its Other financing activities was $270,000 in Q3 2025, compared to -$315,000 in Q2 2025 and -$232,000 in Q1 2025.